Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,264 signal articles · 41 in last 24h · 115,304 total before filter · latest 34m ago
41last 24h
1803last 7d
301● bullish (7d)
170● bearish (7d)
205publishers
AllMacro321Earnings847M&A104Regulatory25Product16Analyst25
✕ clear all filtersticker: ^IXICSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
U.S. Stocks Down as Oil Rises Ahead of Inflation Data
The Wall Street Journal4d agoneutral
U.S. Stocks Down as Oil Rises Ahead of Inflation Data

U.S. stocks slid as negotiations about the future of the Strait of Hormuz remain deadlocked, pushing oil prices up ahead of key inflation data Wednesday. Oil futures rose $1.07, or 1.3%, to $83.20 a barrel, amid signs that the Middle East conflict may escalate again. The yield on the 10-year Treasury note declined 0.014 percentage point to 4.683%.

Yen Intervention Wears Off
The Wall Street Journal4d agoneutral
Yen Intervention Wears Off

U.S. forces fired on a Panama-flagged ship that attempted to run the American blockade of Iranian ports early Tuesday, The Wall Street Journal reported. Brent crude briefly touched $90 a barrel, ending the trading day up 1.4% to $88.91. The Dow ended down 184 points, or 0.3%.

Braveheart Bio (BRVE) Raised $382.5 Million In Its IPO
Simply Wall St.4d agoneutral
Braveheart Bio (BRVE) Raised $382.5 Million In Its IPO

Braveheart Bio (NasdaqGM: BRVE) completed its IPO and listed on the Nasdaq Global Market, with trading commencing before 11 August 2026. The company was added to the NASDAQ Composite Index shortly after the IPO, bringing the stock into a broad market benchmark. Following the listing and index inclusion, Braveheart Bio filed a large shelf registration to provide flexibility for future capital raises. This kind of rapid move from IPO to index inclusion has drawn attention to founder-led...